Disease-specific overall survival in endometrioid ovarian
Por um escritor misterioso
Descrição

Endometrioid Carcinoma of the Ovary
Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers, BMC Cancer

Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States

Frontiers Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study

Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - European Journal of

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial - The Lancet Oncology

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway - Fortner - 2023 - International Journal of Cancer - Wiley Online Library

PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair
de
por adulto (o preço varia de acordo com o tamanho do grupo)